Overall, the frequency and type of mutations observed in the TP53, CDKN2A, PIK3CA, and HRAS genes were consistent with both previous genetic studies of OSCC as well as the TCGA HNSCC dataset [18–21]. This evidence concerns the gene CDKN2A and head and neck squamous cell carcinoma.